Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer
US9133097B2 · kind B2 · utility
0Cited by
2References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 24, 2014 |
| Grant date | Sep 15, 2015 |
| Priority date | — |
| Expiry date | Apr 24, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to unsaturated sphingosine compounds which are useful as therapeutic agents for the treatment of cancer and for the treatment of other diseases including diabetes and infection with intracellular bacteria. The invention is also directed to methods of using the compounds and pharmaceutical compositions comprising the compounds in treating these diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.